Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1617471000001114 | Farydak 20mg capsules (Durbin Plc) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1617481000001111 | Farydak 20mg capsules (Durbin Plc) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2034021000001113 | Farydak 20mg capsules (Secura Bio (Ireland) Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2034041000001115 | Farydak 20mg capsules (Secura Bio (Ireland) Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
98592101000001119 | Farydak 20mg capsules (Novartis Pharmaceuticals UK Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
98592201000001114 | Farydak 20mg capsules (Novartis Pharmaceuticals UK Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Farydak 20mg capsules (Secura Bio (Ireland) Ltd) 6 capsule | Has AMP | True | Farydak 20mg capsules (Secura Bio (Ireland) Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets